vinblastine sulfate- vinblastine sulfate injection
fresenius kabi usa, llc - vinblastine sulfate (unii: n00w22yo2b) (vinblastine - unii:5v9klz54cy) - vinblastine sulfate 1 mg in 1 ml - vinblastine sulfate injection is indicated in the palliative treatment of the following: i. frequently responsive malignancies - generalized hodgkin’s disease (stages iii and iv, ann arbor modification of rye staging system) - lymphocytic lymphoma (nodular and diffuse, poorly and well differentiated) - histiocytic lymphoma - mycosis fungoides (advanced stages) - advanced carcinoma of the testis - kaposi’s sarcoma - letterer-siwe disease (histiocytosis x) ii. less frequently responsive malignancies - choriocarcinoma resistant to other chemotherapeutic agents - carcinoma of the breast, unresponsive to appropriate endocrine surgery and hormonal therapy current principles of chemotherapy for many types of cancer include the concurrent administration of several antineoplastic agents. for enhanced therapeutic effect without additive toxicity, agents with different dose-limiting clinical toxicities and different mechanisms of action are generally selected. therefore, although vinblastine
vinblastine sulfate injection solution
sandoz canada incorporated - vinblastine sulfate - solution - 1mg - vinblastine sulfate 1mg - antineoplastic agents
vinblastine sulfate injection solution
pfizer canada ulc - vinblastine sulfate - solution - 1mg - vinblastine sulfate 1mg - antineoplastic agents
vinblastine sulphate injection solution
teva canada limited - vinblastine sulfate - solution - 1mg - vinblastine sulfate 1mg - antineoplastic agents
vinblastine sulphate (hospira)
hospira nz ltd - vinblastine sulfate 10mg - powder for injection - 10 mg - active: vinblastine sulfate 10mg excipient: benzyl alcohol sodium chloride water for injection
vinblastine 10mg/10ml solution for injection vials
pfizer ltd - vinblastine sulfate - solution for injection - 1mg/1ml
vinblastine sulfate 1mg/ml solution for injection or infusion
pfizer healthcare ireland - vinblastine sulfate - solution for injection/infusion - 1 milligram(s)/millilitre - vinca alkaloids and analogues; vinblastine
blastovin teva
abic marketing ltd, israel - vinblastine sulfate - solution for injection - vinblastine sulfate 1 mg / 1 ml - vinblastine - vinblastine - vinblastine has proved effective in the treatment of the following neoplasms, either alone or in conjunction with other oncolytic drugs:frequently responsive malignancies :• generalized hodgkin's disease (stages iii and iv, ann arbor modification of rye staging system)• non-hodgkin's lymphoma: - reticulum-cell sarcoma - lymphosarcoma• mycosis fungoides.• neuroblastoma.• histiocytosis x.less frequently responsive malignancies :• choriocarcinoma resistant to other chemotherapeutic agents.• embryonal carcinoma of the testis.• carcinoma of the breast, unresponsive to appropriate endocrine surgery and hormonal therapy.
vinblastine teva 1 mg/ml inj. sol. i.v. vial
teva pharma belgium sa-nv - vinblastine sulfate 1 mg/ml - solution for injection - 1 mg/ml - vinblastine sulfate 1 mg/ml - vinblastine
vinblastine sulfate 1 mg/ml solution for inj/inf
hospira uk limited - vinblastine sulfate - solution for inj/inf - 1 mg/ml - vinca alkaloids and analogues